Products & Services
Markets
Contact Us
Become a Partner
Blog
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Products & Services
Markets
Contact Us
Become a Partner
Blog
Reach out to us on
0120-4918900
Or
Get a call back
Click here
Markets
Company Info
Equity
IPO
Company Info
Derivatives
News
Announcements
Mutual Fund
Insurance
Share Price
Live Quotes
Company Profile
Board of Directors
Income Statement
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
QUARTERLY RESULTS
You can view the Quarterly results for the last 5 years.
Ajanta Pharma Ltd.
GO
Jun 25
BSE
3177.90
( -75.80 -2.33%)
Volume
1749
Prev. Close
3253.70
Open Price
3283.90
Today's Low / High
3163.40
3283.90
Bid. Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
2335.00
3314.80
Jun 25
NSE
3180.40
( -75.30 -2.31%)
Volume
37311
Prev. Close
3255.70
Open Price
3266.00
Today's Low / High
3160.60
3266.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
2329.90
3314.90
ISIN No
INE031B01049
Market Cap. (
in Cr. )
39727.04
P/BV
8.78
Book Value (
)
362.42
BSE Code
532331
52 Week High/Low (
)
3315/2330
FV/ML
2/1
P/E(X)
37.62
NSE Code
AJANTPHARMEQ
Book Closure
10/11/2025
EPS (
)
84.54
Div Yield (%)
0.88
Date
Purpose
05/05/2026
Audited Results
30/01/2026
Quarterly Results
03/11/2025
Quarterly Results & Interim Dividend
28/07/2025
Quarterly Results & Others
30/04/2025
Audited Results & A.G.M.
30/01/2025
Quarterly Results
28/10/2024
Quarterly Results
30/07/2024
Quarterly Results
02/05/2024
Audited Results & Buy Back of Shares
31/01/2024
Quarterly Results & 2nd Interim Dividend